Metabolic syndrome is a condition marked by a complex set of physiological, biochemical, and metabolic factors, such as abdominal obesity, insulin resistance, high blood pressure, and dyslipidaemia.
Read moreDuring the last decades, the prevalence of some non-communicable diseases, such as hyperlipidaemia, has been increasing globally. A recent meta-analysis conducted in the Middle East found a pooled prevalence of 32.09% for elevated low-density lipoprotein cholesterol (LDL-C).1 Increased blood levels of LDL-C, classified as hyperlipidaemia, is a well-established causal risk factor for atherosclerotic cardiovascular disease (ASCVD)
Read moreThresholds for hypertension diagnosis differ depending if blood pressure (BP) is measured in the office, at home or ambulatory (daytime, night-time and 24 hours values) according to European guidelines.
Read moreAcross major guidelines, low-density lipoprotein cholesterol (LDL-C) remains the primary target for atherosclerotic cardiovascular disease (ASCVD) prevention, although other guidelines (e.g. United Kingdom) propose non-high-density lipoprotein cholesterol (non-HDL-C) as the main metric for monitoring ASCVD. The primary aim of LDL-C management is to achieve the lowest possible levels through appropriate treatment intensification, while tailoring it to the patient’s cardiovascular risk category, with particular attention to those at high or very high risk.
Read moreMetabolic syndrome and prediabetes are distinct entities with different diagnostic criteria, but they share key components.
Read moreObesity and overweight are a growing health issue. In 2022, 2.5 billion adults (18 years and older) were overweight, of these, 890 million were living with obesity, and these values are expected to continue rising in the following years. The consequences of obesity are vast, ranging from increased risk for cardiovascular diseases (CVDs) and type 2 diabetes, to impaired quality of life.
Read moreMetabolic syndrome is a complex set of interconnected physiological, biochemical, and metabolic factors that contribute to the development of several chronic conditions, such as cardiovascular disease or type 2 diabetes.
Read more
